No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
641 |
4. Check minimum number of eventsNone |
641 |
5. Include endpoints |
769 |
6. Filter based on genotype QC (FinnGen only) |
748 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium masculinorum
Benign neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5564 | - | 5564 |
| Only index persons | 4801 | - | 4801 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | - | 0.16 |
| Only index persons | 0.18 | - | 0.18 |
| Median age at first event (years) | |||
| Whole population | - | - | 52.91 |
| Only index persons | - | - | 50.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 748 | - | 748 |
| Unadjusted period prevalence (%) | 0.34 | - | 0.34 |
| Median age at first event (years) | 58.88 | - | 58.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 769
- Matched controls
- 7690
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
501.2
253.8
240
7
D29.2
ICD-10 Finland
Benign neoplasm: Testis
1417.9
126.8
120
*
D29.3
ICD-10 Finland
Benign neoplasm: Epididymis
+∞
112.3
105
*
D29.4
ICD-10 Finland
Benign neoplasm: Scrotum
258.9
110.9
111
5
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
33.3
103.2
67
22
KFC00
NOMESCO Finland
Unilateral orchiectomy
16.9
71.6
61
39
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
53.8
51
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.2
46.3
84
149
22200
ICD-8 Finland
Benign neoplasm of male genital organs, Testis
+∞
27.2
26
*
22288
ICD-8 Finland
Benign neoplasm of male genital organs, Loco alio definito
+∞
26.2
25
*
KFD16
NOMESCO Finland
Partial excision of epididymis
31.3
25.2
33
11
KFA00
NOMESCO Finland
Exploration of testis
26.8
19.2
26
10
2223A
ICD-9 Finland
Benign neoplasm of male genital organs, Epididymis
+∞
18.8
18
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
18.1
53
140
D29.9
ICD-10 Finland
Benign neoplasm: Male genital organ, unspecified
+∞
17.8
17
*
2220A
ICD-9 Finland
Benign neoplasm of male genital organs, Testis
+∞
16.7
16
*
22210
ICD-8 Finland
Benign neoplasm of male genital organs, Penis
+∞
14.6
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.1
14.6
172
937
Y05
ICPC
Scrotum/testis sympt/compl other
5.2
14.2
29
57
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.1
14.0
147
766
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.1
13.7
161
876
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
76.5
13.6
15
*
ZXC96
NOMESCO Finland
Robot assisted procedure
3.6
13.4
45
131
N40
ICD-10 Finland
Hyperplasia of prostate
1.8
13.2
346
2429
KGB00
NOMESCO Finland
Biopsy of penis
23.0
12.9
18
8
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
3.3
12.8
48
150
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
12.6
196
1171
D29.7
ICD-10 Finland
Benign neoplasm: Other male genital organs
+∞
12.5
12
*
22280
ICD-8 Finland
Benign neoplasm of male genital organs, Scroti
+∞
12.5
12
*
XKD00
NOMESCO Finland
Uroflowmetry
1.8
12.5
230
1450
UKC02
NOMESCO Finland
Cystoscopy
1.9
12.1
192
1153
N43.4
ICD-10 Finland
Spermatocele
3.6
12.0
39
111
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
47.4
11.9
14
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.4
11.7
42
128
XJH00
NOMESCO Finland
Transanal ultrasonography
2.2
11.0
97
469
NK6AN
NOMESCO Finland
Total body bone isotope imaging
3.5
11.0
37
108
J01DB01
ATC
cefalexin; oral
1.8
10.6
600
5081
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
9.8
139
800
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
9.1
83
407
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
12.9
8.4
14
11
22299
ICD-8 Finland
Benign neoplasm of male genital organs, Unspecified site
+∞
8.3
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.2
314
2350
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
22.3
8.0
11
5
M02AA10
ATC
ketoprofen; topical
1.9
7.9
107
605
G04CA02
ATC
tamsulosin; oral
1.5
7.9
339
2598
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
12.0
7.6
13
11
KFW96
NOMESCO Finland
Other operation on scrotum or scrotal organs
25.3
7.6
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.5
195
1325
KFD96
NOMESCO Finland
Other excision or ligature of scrotal organs
80.8
7.4
8
*
C05AA08
ATC
fluocortolone; rectal, topical
1.9
7.1
98
558
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.3
6.8
17
40
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
40.4
6.8
8
*
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
40.4
6.8
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.6
204
1441
L03
ICPC
Low back symptom/complaint
1.6
6.2
153
1023
KFD30
NOMESCO Finland
Operation for spermatocele
4.0
6.2
17
43
S18
ICPC
Laceration/cut
1.5
6.2
330
2606
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
3.7
6.1
19
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
42
24
18.45
51.85
3.9
2.4
31.73
63.84
u/l
—
6
5
20
13
15.75
12.67
3.3
2.5
—
—
—
0
0
130
744
1.90
9.30
5.5
4.7
31.14
30.91
%
0.08
84
511
538
4510
1.64
8.86
6.3
5.1
2.65
2.95
ug/l
0.24
473
4027
451
3716
1.52
7.23
5.1
4.2
142.89
1301.57
e6/l
—
9
68
396
3228
1.47
6.35
17.1
18.8
1.32
1.38
inr
0.48
122
917
132
852
1.66
6.15
4.7
4.1
231.59
245.28
u/l
0.90
126
804
387
3172
1.44
5.85
6.7
7.2
11.87
13.17
umol/l
1.99
376
3026
137
913
1.61
5.60
2.6
2.3
12.15
13.48
nmol/l
1.10
116
817
524
4573
1.46
5.47
8.6
8.3
77.49
80.31
u/l
0.75
493
4319
555
4900
1.48
5.44
3.8
3.8
1.91
2.04
mu/l
1.35
487
4407
38
173
2.26
5.05
1.6
1.4
6.13
5.92
u/l
0.05
28
140
380
3163
1.40
4.97
2.4
2.5
—
—
—
0
0
635
5803
1.54
4.90
17.8
17.0
28.07
29.88
mg/l
0.58
528
4725
436
3752
1.37
4.47
5.1
5.7
6.68
6.92
mmol/l
1.86
415
3569
333
2747
1.37
4.43
7.1
7.3
1.20
1.20
mmol/l
0.55
295
2514
359
3001
1.37
4.38
7.9
8.1
1.20
1.20
mmol/l
0.20
291
2552
48
254
1.95
4.36
1.8
1.8
—
—
—
0
0
334
2765
1.37
4.32
2.7
2.9
—
—
—
0
0
476
4176
1.37
4.19
4.2
3.9
12.41
12.84
mm/h
0.21
434
3841
238
1872
1.39
4.19
2.3
2.2
289.34
294.19
u/l
0.02
223
1755
51
281
1.87
4.12
2.1
1.9
—
—
—
0
0
651
6038
1.51
4.09
21.2
20.2
139.69
139.62
mmol/l
0.27
631
5892
653
6061
1.51
4.09
21.3
20.4
4.02
4.04
mmol/l
1.00
633
5912
335
2803
1.35
3.94
6.0
6.4
25.16
25.80
%
0.47
309
2648
329
2750
1.34
3.87
5.5
6.2
59.29
58.59
%
0.48
298
2603
239
1917
1.36
3.65
3.3
2.9
57.79
101.12
u/l
0.53
225
1795
288
2392
1.33
3.44
3.9
3.5
—
—
—
0
0
60
368
1.68
3.42
2.1
1.8
—
—
—
0
0
246
2000
1.34
3.40
4.0
3.5
44.11
116.01
e6/l
1.29
200
1605
68
436
1.61
3.27
1.4
1.6
—
—
—
0
0
238
1937
1.33
3.24
3.1
3.7
36.26
37.90
u/l
0.19
223
1842
383
3332
1.30
3.19
8.9
9.5
4.47
4.38
e9/l
0.24
343
2909
680
6433
1.49
3.17
26.4
24.2
229.56
230.48
e9/l
0.14
661
6249
680
6433
1.49
3.17
26.5
24.5
40.99
41.67
%
0.41
632
5955
264
2190
1.31
3.12
2.8
2.8
181.28
201.37
ug/l
0.62
237
1998
54
331
1.68
3.10
2.0
1.7
—
—
—
0
0
680
6439
1.48
3.09
26.4
24.1
4.57
4.57
e12/l
0.04
656
6236
680
6440
1.48
3.08
26.6
24.3
138.39
139.09
g/l
0.49
668
6324
296
2499
1.30
3.06
2.0
2.1
92.65
91.91
pmol/l
0.08
161
1415
589
5466
1.33
2.85
17.3
15.6
78.28
78.43
ml/min/173m2
0.05
490
4603
102
744
1.43
2.71
8.0
8.4
—
—
—
0
0
176
1404
1.33
2.70
3.1
2.7
2.65
2.99
e6/l
0.40
160
1261
51
322
1.63
2.65
5.1
4.1
23.98
24.92
mmol/l
1.76
44
300
239
2012
1.27
2.43
2.2
2.2
75.75
74.78
nmol/l
0.21
201
1774
144
1136
1.33
2.38
1.7
1.9
—
—
—
0
0
49
317
1.58
2.33
1.8
1.8
37.97
39.17
nmol/l
0.13
49
305
416
3752
1.24
2.25
3.0
3.1
15.03
14.95
pmol/l
0.24
367
3347
215
1802
1.27
2.24
3.9
3.4
0.55
0.52
e6/l
0.03
169
1423
430
3894
1.24
2.23
3.5
3.4
55.56
60.23
u/l
0.54
397
3624
609
5742
1.29
2.19
4.6
4.6
4.32
4.36
mmol/l
0.49
544
5282
650
6185
1.33
2.16
11.9
11.0
28.49
29.65
u/l
0.65
620
5969
292
2546
1.24
2.14
4.3
4.0
42.14
57.99
ng/l
0.93
225
1940
16
77
2.10
1.97
1.7
1.4
113.16
172.24
pmol/l
1.59
16
77
180
1499
1.26
1.96
2.6
2.7
—
—
—
0
0
236
2032
1.23
1.91
3.2
3.3
2047.40
1933.23
ng/l
0.11
197
1770
49
334
1.50
1.89
1.9
2.1
1.23
1.38
ug/l
0.11
37
296
151
1239
1.27
1.86
1.8
1.8
1139.80
1164.58
nmol/l
0.09
106
954
9
35
2.59
1.80
2.4
1.9
—
—
—
0
0
9
35
2.59
1.80
2.4
1.9
—
—
—
0
0
23
131
1.78
1.79
1.7
1.5
—
—
—
0
0
594
5628
1.24
1.77
5.2
4.8
6.03
6.15
mmol/l
1.46
523
5075
16
81
2.00
1.75
2.8
3.1
—
—
—
0
0
585
5538
1.24
1.73
4.2
4.1
1.32
1.35
mmol/l
0.37
517
5033
35
226
1.57
1.73
1.8
3.0
0.53
1.52
g/l
1.32
26
202
600
5696
1.24
1.73
4.8
4.6
1.32
1.29
mmol/l
0.85
538
5198
615
5857
1.25
1.71
5.0
5.1
2.57
2.60
mmol/l
0.37
550
5344
15
75
2.02
1.70
1.8
1.6
—
—
—
0
0
15
75
2.02
1.70
1.8
1.6
—
—
—
0
0
295
2624
1.20
1.69
3.6
3.1
0.67
0.77
ug/l
1.78
213
1754
187
1590
1.23
1.69
2.2
2.1
2.97
3.02
mg/l
0.12
159
1357
15
76
1.99
1.65
1.8
1.6
—
—
—
0
0
15
77
1.97
1.60
1.8
1.6
—
—
—
0
0
15
77
1.97
1.60
1.8
1.6
—
—
—
0
0
113
913
1.28
1.59
2.8
2.9
21.96
23.93
%
0.88
97
788
8
33
2.44
1.54
2.8
2.9
—
—
—
0
0
36
242
1.51
1.52
2.0
2.9
9.74
11.15
g/l
1.02
28
216
396
3641
1.18
1.51
4.7
4.4
19.78
21.22
%
1.29
209
1795
118
966
1.26
1.50
2.6
2.8
2.13
2.21
g/l
0.87
105
902
35
235
1.51
1.49
2.8
3.3
—
1.15
—
0
22
6
22
2.74
1.43
3.0
2.6
195.17
211.68
u/l
—
6
22
11
53
2.09
1.39
1.5
1.5
—
—
—
0
0
21
127
1.67
1.38
1.4
1.2
—
36.00
—
0
5
38
265
1.46
1.37
2.0
2.8
6.93
7.14
g/l
0.33
31
238
38
265
1.46
1.37
2.0
2.8
—
—
—
0
0
38
265
1.46
1.37
2.0
2.8
3.27
3.54
g/l
0.83
31
238
6
23
2.62
1.37
3.2
3.6
—
—
—
0
0
6
23
2.62
1.37
3.2
3.6
—
—
—
0
0
298
2695
1.17
1.35
5.2
5.8
34.80
34.92
g/l
0.12
270
2510
90
1109
0.79
1.35
4.0
3.4
2.45
2.45
mmol/l
0.32
81
981
73
571
1.31
1.33
3.1
2.8
65.97
65.89
g/l
0.03
61
526
54
404
1.36
1.32
1.6
1.5
—
—
—
0
0
63
483
1.33
1.32
4.3
3.1
60.91
62.88
ml/min/173m2
0.18
32
200
129
1085
1.23
1.30
3.6
3.2
1.23
0.58
e6/l
0.74
78
669
39
277
1.43
1.29
2.4
2.5
201.85
609.41
ug/l
1.40
34
269
48
355
1.38
1.27
1.3
1.9
1.73
1.52
g/l
0.77
39
313
133
1126
1.22
1.26
3.3
3.0
1.10
0.90
e6/l
0.27
79
707
6
25
2.41
1.24
2.7
1.2
0.15
0.17
nmol/l
—
6
16
148
1268
1.21
1.24
3.9
3.9
205.45
463.16
ng/l
1.25
128
1070
123
1037
1.22
1.22
2.7
2.8
12.07
12.98
umol/l
0.74
112
973
30
205
1.48
1.21
1.3
2.8
38.16
37.07
g/l
0.36
23
179
6
26
2.32
1.19
1.0
1.1
—
—
—
0
0
8
38
2.12
1.18
1.4
1.5
—
—
—
0
0
8
38
2.12
1.18
1.4
1.5
—
—
—
0
0
35
249
1.42
1.17
1.4
2.8
2.64
2.92
g/l
1.40
28
223
13
72
1.82
1.15
6.2
4.6
54.81
55.73
%
—
8
67
13
73
1.79
1.11
1.9
1.6
—
—
—
0
0
7
31
2.27
1.10
2.9
2.0
—
—
—
0
0
7
31
2.27
1.10
2.9
2.0
—
—
—
0
0
17
104
1.65
1.10
1.6
1.5
—
—
—
0
0
199
1770
1.17
1.09
3.2
3.0
4704.64
6770.64
umol/l
0.27
177
1544
7
32
2.20
1.08
2.9
1.9
—
—
—
0
0
510
4857
1.15
1.05
19.8
20.0
15.76
15.18
%
1.02
501
4768
9
46
1.97
1.04
1.3
1.5
—
—
—
0
0
69
559
1.26
1.00
3.0
2.6
34.81
41.64
u/l
0.38
62
487
19
124
1.55
0.97
1.1
1.3
—
—
—
0
0
293
2702
1.14
0.96
5.1
4.6
0.00
0.00
estimate
-0.00
62
532
34
252
1.37
0.93
1.8
1.8
35.22
38.83
u/l
0.43
29
225
65
528
1.25
0.93
4.8
3.7
4.99
5.15
kpa
0.84
59
504
171
1522
1.16
0.93
1.5
1.6
18.65
19.08
nmol/l
0.14
141
1300
86
721
1.22
0.93
2.8
3.2
8.97
10.83
umol/l
0.26
75
653
76
629
1.23
0.93
3.1
2.5
0.21
0.21
g/l
0.03
70
576
296
2741
1.13
0.90
4.0
3.5
0.00
0.00
estimate
-0.00
58
495
52
416
1.27
0.86
4.8
5.1
108.08
112.96
ng/l
0.10
46
366
61
498
1.24
0.85
4.9
3.8
0.71
1.79
mmol/l
1.42
46
367
18
121
1.50
0.83
3.4
3.3
62.89
56.58
%
1.15
18
121
8
46
1.75
0.82
1.4
1.5
—
—
—
0
0
27
198
1.38
0.81
1.2
1.3
—
—
—
0
0
6
34
1.77
0.76
1.3
1.8
—
—
—
0
0
6
34
1.77
0.76
1.3
1.8
—
—
—
0
0
17
116
1.48
0.74
3.2
3.1
5.11
4.42
e9/l
0.36
17
116
123
1088
1.16
0.74
4.1
3.7
0.80
0.82
mmol/l
1.04
114
1027
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
562
5441
1.12
0.72
6.8
6.3
40.55
40.84
mmol/mol
0.31
494
5019
77
658
1.19
0.71
3.2
4.3
2.26
1.82
mmol/l
0.54
63
539
5
26
1.93
0.70
1.4
1.7
—
2284600.00
—
0
5
92
800
1.17
0.70
1.4
1.8
—
—
—
0
0
292
2737
1.11
0.69
4.0
3.5
0.00
0.00
estimate
0.50
62
557
10
61
1.65
0.68
1.0
1.1
—
—
—
0
0
10
61
1.65
0.68
1.1
1.0
—
—
—
0
0
18
127
1.43
0.68
2.0
1.9
—
—
—
0
0
18
127
1.43
0.68
1.1
1.1
—
—
—
0
0
15
102
1.48
0.68
1.1
1.6
—
—
—
0
0
7
43
1.63
0.67
1.3
1.7
—
—
—
0
0
13
86
1.52
0.66
3.4
2.4
—
—
—
0
0
5
28
1.79
0.66
1.0
4.1
—
49629.22
—
0
9
5
28
1.79
0.66
1.6
1.9
435.40
1779.11
u/ml
—
5
28
12
178
0.67
0.65
1.1
1.5
—
—
—
0
0
148
1348
1.12
0.59
1.7
1.7
110924805.26
18878415.65
pmol/l
0.61
119
1123
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
5
90
0.55
0.56
1.2
1.4
—
—
—
0
0
23
177
1.31
0.55
1.8
1.8
—
—
—
0
0
21
161
1.31
0.52
1.2
1.3
1.07
1.15
g/l
1.02
21
155
18
135
1.34
0.51
3.7
1.9
0.91
0.83
nmol/l
0.28
13
118
11
75
1.47
0.51
3.6
2.4
—
—
—
0
0
10
67
1.50
0.50
1.1
1.0
—
—
—
0
0
22
172
1.29
0.48
1.8
1.8
—
—
—
0
0
10
68
1.48
0.47
2.3
1.7
—
—
—
0
0
10
68
1.48
0.47
2.3
1.7
—
—
—
0
0
10
68
1.48
0.47
2.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
284
1.21
0.44
2.1
2.5
0.29
0.33
u/ml
0.23
15
154
20
157
1.28
0.43
1.2
1.3
0.22
0.24
g/l
0.80
20
150
16
122
1.32
0.42
1.3
1.1
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
16
123
1.31
0.40
1.9
1.8
—
—
—
0
0
16
123
1.31
0.40
1.9
1.8
—
—
—
0
0
19
151
1.26
0.39
3.4
3.8
37.80
29.68
mg/l
0.18
11
103
11
80
1.38
0.38
2.2
1.9
—
—
—
0
0
5
36
1.39
0.38
4.0
4.2
844.80
89.11
nmol/l
—
5
36
10
136
0.73
0.38
1.6
1.1
—
—
—
0
0
142
1518
0.92
0.37
1.7
1.7
1.39
1.43
mmol/l
0.22
123
1247
164
1542
1.08
0.37
4.5
3.7
0.00
0.01
estimate
0.69
60
488
55
488
1.14
0.37
1.8
1.7
—
—
—
0
0
5
37
1.35
0.37
5.2
3.7
—
—
—
0
0
6
44
1.37
0.34
2.2
2.2
24.67
16.73
%
—
6
44
68
616
1.11
0.34
1.6
1.3
—
—
—
0
0
17
210
0.81
0.33
2.9
2.3
101.22
113.86
ug/min
—
9
123
22
264
0.83
0.33
4.1
4.0
402.65
4994.43
u/ml
0.62
17
218
25
210
1.20
0.33
1.6
1.7
—
—
—
0
0
80
733
1.10
0.33
1.2
1.2
51.71
37.26
iu/ml
0.20
23
206
38
433
0.87
0.32
1.9
1.8
—
—
—
0
0
12
154
0.78
0.32
1.4
1.6
188.59
264.37
ug/g
—
7
98
102
948
1.09
0.31
7.9
7.2
1.05
1.01
mmol/l
0.76
94
889
30
258
1.17
0.31
1.1
1.3
990.39
258.49
u/ml
0.48
25
231
7
55
1.28
0.30
1.4
1.7
—
—
—
0
0
19
157
1.22
0.29
2.5
1.9
14.24
12.16
mg/l
0.45
19
145
223
2139
1.06
0.29
4.2
3.7
—
—
—
0
0
35
307
1.15
0.29
2.3
3.0
—
—
—
0
0
16
130
1.24
0.29
1.1
1.6
—
—
—
0
0
56
616
0.90
0.28
2.6
3.0
296.18
234.48
ng/l
0.30
50
560
56
510
1.11
0.27
1.7
2.3
384.66
365.01
nmol/l
0.35
50
462
16
193
0.83
0.27
1.2
1.2
—
—
—
0
0
10
77
1.30
0.26
2.3
1.9
—
—
—
0
0
5
75
0.66
0.26
4.0
3.8
—
—
—
0
0
73
676
1.09
0.25
1.3
1.2
2.49
13.15
u/ml
2.72
24
256
12
148
0.81
0.24
1.8
2.4
121.67
130.26
g/l
—
6
114
86
804
1.08
0.24
1.4
1.9
—
—
—
0
0
125
1186
1.06
0.24
1.6
1.7
1.27
1.51
mg/l
0.51
98
929
14
169
0.83
0.24
3.5
9.8
104.64
105.56
mmol/l
0.45
14
151
16
190
0.84
0.23
1.9
1.7
—
—
—
0
0
5
39
1.28
0.23
2.4
2.5
—
—
—
0
0
5
39
1.28
0.23
1.2
1.6
1.13
1.01
g/l
—
5
39
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
79.83
—
0
6
0
11
0.00
0.21
0.0
1.2
—
85.17
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
10
80
1.25
0.20
1.5
1.8
—
—
—
0
0
21
183
1.15
0.20
1.2
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
6
50
1.20
0.19
2.2
1.6
81.67
90.30
umol/l
—
6
50
18
207
0.87
0.19
1.2
1.1
27.61
155.29
iu/ml
—
9
70
7
60
1.17
0.18
1.3
1.1
—
—
—
0
0
201
2068
0.96
0.17
4.6
4.0
12.45
11.24
mg/mmol
0.09
134
1436
8
68
1.18
0.16
2.5
1.1
—
—
—
0
0
75
711
1.06
0.16
7.5
8.7
10.87
10.95
mmol/l
0.03
69
677
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
6
78
0.77
0.15
1.2
2.4
—
—
—
0
0
6
80
0.75
0.15
1.0
1.0
—
—
—
0
0
7
89
0.78
0.14
1.3
1.7
—
—
—
0
0
7
89
0.78
0.14
1.3
1.7
—
—
—
0
0
17
191
0.89
0.14
1.0
1.0
—
—
—
0
0
74
708
1.05
0.12
4.2
3.5
—
—
—
0
0
10
116
0.86
0.12
1.0
1.1
—
—
—
0
0
13
114
1.14
0.12
1.2
1.5
—
—
—
0
0
79
822
0.96
0.11
2.1
2.0
1.58
1.63
%
0.19
66
703
202
2062
0.97
0.11
3.9
3.4
8.02
8.48
mmol/l
0.79
162
1728
37
348
1.07
0.10
2.7
3.8
25.06
25.01
mmol/l
0.03
37
335
21
193
1.09
0.10
1.4
1.4
—
—
—
0
0
15
135
1.11
0.09
1.2
1.1
—
—
—
0
0
15
135
1.11
0.09
1.2
1.1
—
—
—
0
0
14
155
0.90
0.09
1.1
1.5
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
7
66
1.06
0.08
1.6
2.0
—
—
—
0
0
8
74
1.08
0.07
1.1
1.3
—
8.31
—
0
26
88
858
1.03
0.07
7.1
9.1
5.02
5.10
kpa
0.34
81
824
16
173
0.92
0.06
1.1
1.4
—
—
—
0
0
88
859
1.03
0.06
7.1
9.1
11.67
11.92
kpa
0.18
83
827
16
148
1.08
0.06
1.3
1.3
—
—
—
0
0
16
148
1.08
0.06
1.3
1.3
—
—
—
0
0
94
960
0.98
0.06
1.3
1.2
1.96
1.27
u/ml
0.31
24
259
15
140
1.07
0.04
1.7
1.9
—
—
—
0
0
31
321
0.96
0.03
3.3
4.4
53.75
50.17
%
0.36
31
316
87
857
1.02
0.03
7.3
9.2
1.17
0.99
mmol/l
0.17
74
669
11
102
1.08
0.03
1.2
1.6
—
—
—
0
0
192
1912
1.01
0.01
3.8
3.6
2.35
2.33
mmol/l
0.81
161
1686
125
1257
0.99
0.00
4.8
3.8
1.02
1.02
kg/l
0.02
20
178
12
126
0.95
0.00
1.2
1.5
25.94
31.35
g/l
0.72
12
112
11
115
0.96
0.00
1.2
1.4
1550.18
1806.04
e6/l
0.12
11
84
11
114
0.96
0.00
1.4
1.3
—
—
—
0
0
10
103
0.97
0.00
1.5
1.7
—
—
—
0
0
19
187
1.02
0.00
1.6
2.5
3.49
3.73
g/l
0.26
19
175
12
122
0.98
0.00
1.2
1.7
—
—
—
0
0
67
667
1.00
0.00
3.9
4.4
4.30
34.23
ug/l
1.61
58
561
10
101
0.99
0.00
1.2
1.1
—
3.64
—
0
8
66
662
1.00
0.00
1.9
2.5
7.50
8.58
ug/l
0.29
52
593
7
75
0.93
0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
9
90
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
16.58
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
1.0
1.2
1.76
1.47
nmol/l
—
6
58
0
5
0.00
-0.00
0.0
2.0
—
1.38
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MALE_GEN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MALE_GEN | 1.301 [1.15, 1.47] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 965 out of 3809 males with CD2_BENIGN_MALE_GEN died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MALE_GEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.238% |
| 5 | No data | 1.447% |
| 10 | No data | 3.479% |
| 15 | No data | 6.681% |
| 20 | No data | 11.102% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MALE_GEN – Benign neoplasm of male genital organs
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data